‼️𝗗𝘂𝗮𝗹 𝗔𝗻𝘁𝗶𝗽𝗹𝗮𝘁𝗲𝗹𝗲𝘁 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 (𝗗𝗔𝗣𝗧) 𝗶𝗻 𝗖𝗼𝗿𝗼𝗻𝗮𝗿𝘆 𝗔𝗿𝘁𝗲𝗿𝘆 𝗗𝗶𝘀𝗲𝗮𝘀𝗲‼️ ⬇️⬇️⬇️⬇️

Prevalence of reduced eGFR in European adults using KDIGO and age-adapted eGFR thresholds Using age-adapted eGFR thresholds would likely cause a shift in the prevalence of reduced kidney function. However, the association between these novel age-adapted thresholds and clinical

EAST-AFNET 4 RCT: Early rhythm control therapy is effective and safe for treating atrial fibrillation in patients with and without #obesity or #diabetes. ja.ma/4lURdgK

#PREVENT Risk Age Equations and Population Distribution in US Adults jamanetwork.com/journals/jamac… JAMA JAMA Cardiology

En la nueva guía de Aldosteronismo Primario, refieren que todos los pacientes con hipertensión arterial deben ser escrutinizados para esta patología; con la concentración plasmática de aldosterona, de renina y con su cociente J Clin Endocrinol Metab 2025 doi.org/10.1210/clinem…

SURPASS-CVOT topline results announced: tirzepatide non-inferior to dulaglutide for MACE-3 reduction among 13k+ type 2 diabetics (0.92, 0.83-1.01). Secondary analysis of all-cause mortality (0.84, 0.75-0.94). lilly.mediaroom.com/2025-07-31-Lil… Eli Lilly and Company $LLY Definitely a risk to take

Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics In SURPASS-CVOT, Mounjaro achieved the primary objective by

🧠 #Adrenal incidentaloma? Imaging is key! ✅ Start with non-contrast #CT 🚩 Red flags → size, heterogeneity, lipid-poor 📉 Young age, hx of malignancy = more caution 💡 Don't forget hormone excess AACE 🔗 doi.org/10.1016/j.epra… #EndoTwitter #MedTwitter #Radiology

Trizepatide Showed Cardiovascular Protection Lilly's New SURPASS-CVOT Press Release Highlights 1️⃣ CV Risk Reduction: Mounjaro (tirzepatide) cut the risk of cardiovascular death, heart attack, or stroke by 8% vs. Trulicity. 2️⃣ Lower Mortality: Mounjaro showed a 16% reduction in

📚 Farmacocinética de linezolid: Revisión sistemática 2023 Evidencia publicada en estudios y sugerencia de ajustes en: 🟡Edades extremas 🟡Obesidad 🟡Embarazo 🟡Insuficiencia hepática 🟡Insuficiencia renal y TRR 🟡Fibrosis quística 🟡Pacientes críticos link.springer.com/article/10.100…

🆕 Just published in Reviews in Cardiovascular Medicine: "Electrophysiology Models for End-Stage Renal Disease Maladaptations That Promote Asystole" ✒️ By Dr. Ike Chinyere Ike Chinyere, MD, PhD (University of Arizona University of Arizona; University Medical Center) 💡 This comprehensive review

High diagnostic accuracy of #YesCCT enables strong FFRCT reproducibility. New #JACCIMG data from Denmark show consistent median FFRCT across 4 serial scans over 18 months using 3rd-gen scanners. jacc.org/doi/10.1016/j.… TIM FAIRBAIRN Kristian Tækker Madsen

🔴Aldosterone and Aldosterone Modulation in Cardio-Kidney Diseases⤵️ 🔹This JACC State-of-the-Art #2025Review describe the role of aldosterone, steroidal and nonsteroidal MRA and aldosterone synthase inhibitors in cardio-kidney diseases. 🔹jacc.org/doi/10.1016/j.… #Cardiology

🔴The Doppler combined assessment of splanchnic perfusion and congestion in cardiogenic shock: a physiological approach⤵️ #2025commentary #OpenAccess 🔹link.springer.com/article/10.100… #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter

The Relevance of Right Ventricular Function and Dimension in Patients Undergoing Transcatheter Tricuspid Edge-to-Edge Repair RV size and function, along with residual TR severity, were significant predictors of clinical outcomes, including all-cause mortality and heart failure

Angina Refractaria. 🤔🫀💥⁉️ 🔶️Se define como una afección crónica (>3 meses) caracterizada por la presencia de angina causada por insuficiencia coronaria en presencia de enfermedad coronaria, que no se puede controlar mediante una combinación de tratamiento médico,

Epigenetics in heart disease: A new frontier in cardiology. 🔔 Full Text: imrpress.com/journal/RCM/26… From DNA methylation to non-coding RNAs, epigenetic regulators like DNMTs, HDACs & TETs play key roles in CVD progression. 🔬 Could targeting them be the future of precision

#SUMMIT El ensayo SUMMIT demostró que en pacientes obesos con HFpEF 🫀, la administración subcutánea 💉 semanal de tirzepatida superó al placebo en la reducción del criterio compuesto de muerte cardiovascular (CV) y eventos relacionados con insuficiencia cardíaca durante 104

Sex Differences in Prehospital Stroke Medicine (SESAME): A Systematic Review and Meta-Analysis | Stroke ahajournals.org/doi/full/10.11…

Phase 2a Study of Baxdrostat in Primary Aldosteronism | New England Journal of Medicine nejm.org/doi/full/10.10…